Celularity Inc. Accumulated Other Comprehensive Income
Celularity Inc. (CELU) had Accumulated Other Comprehensive Income of -$3.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-29.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-04-30
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.00K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.00K.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.40M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-06-30 | -$3.00K 10-Q · filed 2025-08-29 |
| 2024-12-31 | -$5.00K 10-K · filed 2026-04-30 |
| 2024-09-30 | -$2.00K 10-Q · filed 2024-12-06 |
| 2023-09-30 | $2.40M 10-Q · filed 2024-01-03 |
| 2023-06-30 | $2.39M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.67M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $9.00K 10-K · filed 2024-07-30 |
| 2022-09-30 | $236.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |